- Datum20.11.2025
- UhrzeitLäuft gerade
- Veranstalter
stock3
Insmed Inc. Aktie
Verkaufen
Kaufen
Insmed Inc. Chart
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
Insmed Inc. Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
0,92 %
Intraday
6,60 %
1 Woche
21,23 %
1 Monat
194,84 %
Seit Jahresbeginn
180,12 %
1 Jahr
943,90 %
3 Jahre
421,01 %
5 Jahre
1.133,70 %
10 Jahre
Passender Service zu Insmed Inc.
Webinar zu Insmed Inc.
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)60,400-205,110
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Insmed Inc.
Keine Dividenden verfügbar
Termine von Insmed Inc.
- Feb19Insmed Inc.Q4 2025 Earnings Release
- Apr30Insmed Inc.Q1 2026 Earnings Release
- Aug6Insmed Inc.Q2 2026 Earnings Release
Beschreibung
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
